LBRX ▲ +7.5% - LB Pharmaceuticals Inc
$LBRX - LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP Congress
10-OCT-2026 08:00 AM ET
Share this post
More filings for $LBRX
LBRX ▲ +0.3% - LB Pharmaceuticals IncOct 6, 2026LBRX ▲ +0.1% - LB Pharmaceuticals IncSep 15, 2026LBRX ▼ -4.0% - LB Pharmaceuticals IncSep 3, 2026LBRX - LB Pharmaceuticals Inc - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026$LBRX SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026$LBRX SEC Filing Update (16-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 16, 2026
View full $LBRX filing history →💬 Comments
Loading comments…
Leave a comment